Term Paper Undergraduate 2,426 words

L'Oréal Group Corporate Analysis: SWOT and Strategy

~13 min read
Abstract

This paper presents a comprehensive corporate analysis of L'Oréal Group, the world's largest cosmetics company. Beginning with a history of the company's founding in 1909 and its subsequent growth through research, mergers, and product diversification, the paper conducts a SWOT analysis examining internal strengths — particularly L'Oréal's research and development capabilities — alongside weaknesses including misleading advertising controversies and racial discrimination findings. External opportunities such as aging populations, emerging markets, and nutricosmetics are weighed against macroeconomic and legal threats. The paper also evaluates L'Oréal's related-constrained diversification strategy at the corporate level, its differentiation-focused business-level strategy, and its decentralized organizational structure, concluding with targeted recommendations for improvement.

📝 How to Write This Type of Paper Writing guide — click to expand

What makes this paper effective

  • The paper integrates factual company history with analytical frameworks (SWOT, corporate strategy typology) to build a coherent evaluation rather than simply reporting facts.
  • It balances quantitative evidence — R&D headcount, patent filings, financial figures — with qualitative judgments about brand image and advertising controversies, giving the analysis texture and credibility.
  • The recommendations section flows logically from the weaknesses and opportunities identified earlier, demonstrating internal consistency across the paper's argument.

Key academic technique demonstrated

The paper demonstrates applied strategic framework analysis: it uses the SWOT model not as a mechanical checklist but as a scaffold for evaluating competitive positioning. The author links each identified strength or weakness directly to a strategic implication, showing how internal capabilities (R&D investment) translate into competitive advantages, while internal failures (misleading advertising, discrimination) translate into market share risks. This cause-and-effect reasoning distinguishes analysis from mere description.

Structure breakdown

The paper follows a standard corporate-analysis structure: company background → internal analysis (strengths/weaknesses) → external analysis (opportunities/threats) → integrated SWOT evaluation → strategy analysis (corporate-level, then business-level) → structure and control → recommendations. Each section builds on the previous one, ensuring the recommendations are grounded in prior analysis rather than introduced without support.

Company Overview and History

L'Oréal Group is the most prominent cosmetics company in the world. It was founded in 1909 by French chemist Eugène Schueller. The company first operated as a hair dye manufacturer, producing a formula designed to be safe for consumers and sold to hair salons in Paris.

After a decade, the company employed only three chemists. By 1950, L'Oréal had grown to employ 100 researchers. In 1984, the company's products were developed by 1,000 chemists, and that number has doubled since. L'Oréal currently employs 67,660 people worldwide.

Since its establishment, L'Oréal has significantly expanded its range of products. The company began as a hair color producer and has grown into the world's largest cosmetics company, now addressing fields including hair color, skin care, make-up, hair care, sun protection, perfumes, body care, and hairstyling. The pharmaceutical and dermatological fields also play a very important role in the company's activity. In addition, L'Oréal is the most important nanotechnology patent holder in the United States.

The company is well-known for its research and development activity, which has been continuously expanded. L'Oréal currently owns five international research and development centers: two located in France, one in New Jersey (USA), one in Japan, and one in China. A second research and development center is planned for New Jersey.

The pharmaceutical dimension of L'Oréal's activity became apparent when the company purchased Synthelabo in 1973. Following a merger with Sanofi in 1999 and with Aventis in 2004, Synthelabo became Sanofi-Aventis, the third-largest pharmaceutical company in the world and the largest in Europe. L'Oréal currently owns 10.41% of Sanofi-Aventis shares.

L'Oréal's series of significant acquisitions continued with the €652 million takeover of The Body Shop in 2006. This move was strongly disapproved of by The Body Shop's customers, since The Body Shop is a well-known ethical cosmetics company that campaigned against animal testing, while L'Oréal still uses animals for testing new ingredients and products.

Internal Strengths: R&D and Market Experience

L'Oréal and Nestlé have also formed several joint ventures, including Laboratoires Inneov, focusing on nutritional cosmetics, and Galderma, focusing on dermatology.

The company's long presence in the global market has given L'Oréal the experience needed to overcome the threats that inevitably arise in any company's history. The company has endured difficult periods when the global economic and social context worked against the cosmetics sector, and it has emerged with the expertise required to manage such difficulties in the future. Equally, during flourishing market conditions, L'Oréal maintained a stable and consistent position, taking advantage of opportunities as they arose.

The strongest asset of L'Oréal, however, consists in its research and development activity — a guiding principle ever since the company's founding in 1909. The scale of this effort is considerable: 3,268 employees of 60 different nationalities, working across 30 different disciplines, are engaged in R&D. In 1920, this function was carried out by only three chemists.

In 2008, L'Oréal's financial investment in cosmetic and dermatological research amounted to €581 million. Beyond its five major international research centers, the company operates 18 research centers and 13 evaluation centers worldwide. One third of the entire research and development budget is allocated to basic research — considered the starting point for all company innovations — which signals the company's commitment to sustaining long-term creative output.

The results of this investment are tangible: 5,000 formulas are developed each year, and 628 patents were filed in 2008 alone. Furthermore, the company maintains 100 active cooperation agreements with leading academic and research institutions (L'Oréal, 2009).

It is difficult to identify clear weaknesses in a company that has, throughout its history, managed to resolve emerging problems and prevent their recurrence. Nevertheless, one aspect of L'Oréal's business that may prove harmful is its approach to advertising. In an industry like cosmetics, image is central to commercial success — it defines the product, shapes customer perception, and is expressed most visibly through advertising. Advertising is where a company demonstrates how its products differ from the competition, but it can either build or damage brand image.

Internal Weaknesses: Advertising and Control Issues

L'Oréal has faced notable difficulties in this area. In Australia in 2007, the company was ordered by the Therapeutic Goods Administration (TGA) to withdraw advertisements that claimed anti-wrinkle benefits for certain products. The TGA found the advertisements misleading because the products in question were cosmetic rather than therapeutic, as the ads implied (Daily Telegraph, 2007). Although this regulatory action also targeted other cosmetics companies, it nevertheless dealt a significant blow to L'Oréal's image. The suggestion that advertisements were misleading and that products failed to deliver promised outcomes risked undermining consumer confidence across the company's broader product line.

Similarly, advertising for some of the company's mascaras was challenged by the British Advertising Standards Authority for promising effects that products could not realistically deliver. These advertising controversies point to a pattern that, if unaddressed, could have lasting consequences for consumer trust.

A more serious reputational issue emerged in 2007, when the company was found guilty of systematic racial discrimination in France. A promotional campaign for a Garnier product line — one of L'Oréal's key brands — deliberately excluded non-white candidates from promotional roles. The situation was not isolated, and it ultimately led to the company's legal conviction (Africa Resource, 2007).

Such issues are not merely ethical concerns; they carry practical commercial consequences. Certain categories of customers who object to racial discrimination or misleading advertising may reduce or discontinue their purchases. Over the medium and long term, this can translate into reduced sales and a diminished market share.

A further area of concern relates to internal control. Given that L'Oréal operates across several major business fields, manages numerous international brands, and maintains a global presence, maintaining adequate oversight across all parts of the organization is inherently challenging. This difficulty in exercising comprehensive control represents a structural vulnerability for a group of this scale and complexity.

The macroeconomic environment has been significantly affected by the financial and economic crisis, and the cosmetics industry is no exception. It is widely anticipated that the cosmetics market will face challenging conditions in the near term. As in other industries, some companies will manage to overcome these pressures while others may be forced to exit the market. Cosmetics giants like L'Oréal are expected to be better positioned to navigate these difficulties, though the challenges remain real.

Even in difficult times, the environment presents a range of opportunities for companies able to identify and act on them. Industry observers have pointed to the following key trends shaping the cosmetics sector: an aging global population, increased wealth in emerging markets, the pursuit of agelessness, technological advances, and a growing awareness of health and wellness (Lee, 2008).

4 Locked Sections · 1,090 words remaining
Sign up to read these 4 sections

External Opportunities and Threats · 320 words

"Aging demographics, emerging markets, economic risks"

SWOT Analysis Evaluation · 210 words

"Integrated SWOT assessment and nutricosmetics opportunity"

Corporate-Level and Business-Level Strategy · 310 words

"Related diversification and differentiation strategies"

Organizational Structure, Control Systems, and Recommendations · 250 words

"Decentralized structure, brand divisions, and recommendations"

You’re 45% through this paper. Sign up to read the remaining 4 sections.

Sign Up Now — Instant Access Already a member? Log in
130,000+ paper examples AI writing assistant Citation generator Cancel anytime
Key Concepts in This Paper
R&D Investment SWOT Analysis Differentiation Strategy Related Diversification Brand Management Nutricosmetics Emerging Markets Decentralized Structure Advertising Ethics Cosmetics Industry
Cite This Paper
PaperDue. (2026). L'Oréal Group Corporate Analysis: SWOT and Strategy. PaperDue. https://www.paperdue.com/study-guide/loreal-group-corporate-analysis-swot-strategy-21269

Always verify citation format against your institution’s current style guide requirements.